CRISPR Medicine News
Business News
About CRISPR Medicine News
Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Familial Hypercholesterolemia, HeFH, or Premature Coronary Artery Disease, CAD, (NCT06164730)
Sponsors:
Verve Therapeutics, Inc.
Sponsors:
Verve Therapeutics, Inc.
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III